The global market, valued at USD 32.69 billion in 2025, is set to grow at a CAGR of 4.51% as demand for early disease detection and precision diagnostics surges worldwide.Austin, United States, March ...

Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics Q4 2025 Earnings Conference Call. [Operator Instructions] I will now turn the call over to Nicole Riley, Head of Investor ...

Good morning, everyone. Thank you for joining us today for our 2025 full year results presentation. Alongside me is Ben Peacock, our CFO. We're pleased to have the opportunity to walk you through our ...

Earnings call ADCT’s Q4 2025 saw ZYNLONTA net product revenue rise to $22.3M (up from $16.4M YoY), with full-year sales at $73.6M, broadly stable versus 2024. Operating expenses were cut by 15% in Q4, ...